168 related articles for article (PubMed ID: 35783645)
1. Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis.
Jiang YL; Liu HY; Tang MM; Cheng JY; Zhao H; Fu L
Front Med (Lausanne); 2022; 9():798343. PubMed ID: 35783645
[TBL] [Abstract][Full Text] [Related]
2. Serum 8-Hydroxydeoxyguanosine Is a Potential Indicator for the Severity and Prognosis in Patients with Community-Acquired Pneumonia: A Prospective Cohort Study.
Cao LF; Cheng JY; Xu Z; Feng CM; Zhao H; Wang XM; Fu L
J Immunol; 2022 Jan; 208(2):321-327. PubMed ID: 34911771
[TBL] [Abstract][Full Text] [Related]
3. Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study.
Feng CM; Wang XM; Li MD; Xu Z; Hua DX; Cheng JY; Zheng L; Zhao H; Fu L
BMC Pulm Med; 2021 Dec; 21(1):393. PubMed ID: 34856971
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal associations of serum survivin with the severity and prognosis of community-acquired pneumonia patients.
Cheng JY; Tang MM; Fang P; Liu Y; Sun J; He QY; Deng YP; Hou XF; Zhao H; Fu L
Respir Investig; 2023 Jan; 61(1):84-94. PubMed ID: 36336629
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional and longitudinal associations of serum Cysteine-rich 61 with severity and prognosis among community-acquired pneumonia patients in China.
Yao MX; Cheng JY; Liu Y; Sun J; Hua DX; He QY; Liu HY; Fu L; Zhao H
Front Med (Lausanne); 2022; 9():939002. PubMed ID: 36035395
[TBL] [Abstract][Full Text] [Related]
6. Serum SOD1 level predicts the severity and prognosis of community-acquired pneumonia patients.
Xie GF; Cheng JY; Liu Y; Sun J; Hua DX; He QY; Yang J; Zhao H; Lu YJ; Fu L
Am J Med Sci; 2024 May; ():. PubMed ID: 38825074
[TBL] [Abstract][Full Text] [Related]
7. Serum IL-27 predicts the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Xu Z; Wang XM; Cao P; Zhang C; Feng CM; Zheng L; Xu DX; Fu L; Zhao H
Int J Med Sci; 2022; 19(1):74-81. PubMed ID: 34975300
[No Abstract] [Full Text] [Related]
8. Longitudinal associations between serum IL-34 with severity and prognosis in community-acquired pneumonia patients.
Tang F; Hou XF; Cheng Y; Liu Y; Sun J; Liu HY; Lv LP; Fu L
Respir Investig; 2024 Mar; 62(2):223-230. PubMed ID: 38218098
[TBL] [Abstract][Full Text] [Related]
9. Serum TRAIL predicts severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Hua DX; Ma KS; Cheng JY; Liu Y; Sun J; He QY; Deng YP; Yang J; Fu L; Zhao H
Intern Emerg Med; 2022 Nov; 17(8):2279-2290. PubMed ID: 36241932
[TBL] [Abstract][Full Text] [Related]
10. The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study.
Liu HY; Xiang HX; Xiang Y; Xu Z; Feng CM; Fei J; Fu L; Zhao H
BMC Infect Dis; 2021 Apr; 21(1):327. PubMed ID: 33827454
[TBL] [Abstract][Full Text] [Related]
11. Associations of Serum Resistin With the Severity and Prognosis in Patients With Community-Acquired Pneumonia.
Feng CM; Cheng JY; Xu Z; Liu HY; Xu DX; Fu L; Zhao H
Front Immunol; 2021; 12():703515. PubMed ID: 34858392
[TBL] [Abstract][Full Text] [Related]
12. Associations of Serum Clara Cell Protein 16 with Severity and Prognosis in Adults with Community-Acquired Pneumonia.
Li JF; Zou Q; Li X; Liu Y; He QY; Fu L; Zhao H
Int J Gen Med; 2023; 16():4907-4917. PubMed ID: 37928954
[TBL] [Abstract][Full Text] [Related]
13. Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.
Jiang X; Huang CM; Feng CM; Xu Z; Fu L; Wang XM
Front Immunol; 2021; 12():714026. PubMed ID: 34745092
[TBL] [Abstract][Full Text] [Related]
14. Serum 8-iso-PGF2α Predicts the Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Retrospective Cohort Study.
Zheng L; Fei J; Feng CM; Xu Z; Fu L; Zhao H
Front Med (Lausanne); 2021; 8():633442. PubMed ID: 33869248
[No Abstract] [Full Text] [Related]
15. The association between serum complement C3a and severity in patients with community-acquired pneumonia.
Xu Z; Hou XF; Feng CM; Zheng L; Xu DX; Zhao H; Fu L
Front Immunol; 2023; 14():1034233. PubMed ID: 36776834
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.
Wang Y; Zhang S; Li L; Xie J
Arch Gerontol Geriatr; 2019; 80():53-57. PubMed ID: 30366226
[TBL] [Abstract][Full Text] [Related]
17. Admission lysophosphatidylethanolamine acyltransferase level predicts the severity and prognosis of community-acquired pneumonia.
Chen L; Zhao L; Shang Y; Xu Y; Gao Z
Infection; 2021 Oct; 49(5):877-888. PubMed ID: 33694084
[TBL] [Abstract][Full Text] [Related]
18. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.
Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z
Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum 4-HNE and lactic acid levels and disease status in patients with severe pneumonia and its diagnostic value and prognostic evaluation.
Wu H; Pan J
Am J Transl Res; 2023; 15(3):1913-1920. PubMed ID: 37056801
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
